• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

风湿性心脏病全球负担:1990 年至 2019 年趋势。

Global burden of rheumatic heart disease: trends from 1990 to 2019.

机构信息

Department of Central Laboratory, Guangzhou Twelfth People's Hospital, Guangzhou, China.

Key Laboratory of Occupational Environment and Health, Guangzhou Twelfth People's Hospital, Guangzhou, China.

出版信息

Arthritis Res Ther. 2022 Jun 11;24(1):138. doi: 10.1186/s13075-022-02829-3.

DOI:10.1186/s13075-022-02829-3
PMID:35690787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9188068/
Abstract

BACKGROUND

Rheumatic heart disease (RHD) is a critical public health issue worldwide, and its epidemiological patterns have changed over the decades. This article aimed to estimate the global trends of RHD, and attributable risks from 1990 to 2019.

METHODS

Data on RHD burden were explored from the Global Burden of Disease Study 2019. Trends of the RHD burden were estimated using the estimated annual percentage change (EAPC) and age-standardized rate (ASR).

RESULTS

During 1990-2019, increasing trends in the ASR of incidence and prevalence of RHD were observed worldwide, with the respective EAPCs of 0.58 (95% confidence interval [CI] 0.52 to 0.63) and 0.57 (95%CI 0.50 to 0.63). Meanwhile, increasing trends commonly occurred in low and middle Socio-Demographic Index (SDI) regions and countries. The largest increasing trends in the ASR of incidence and prevalence were seen in Fiji, with the respective EAPCs being 2.17 (95%CI 1.48 to 2.86) and 2.22 (95%CI 1.53 to 2.91). However, death and disability-adjusted life years (DALYs) due to RHD showed pronounced decreasing trends of ASR globally, in which the EAPCs were - 2.98 (95%CI - 3.03 to - 2.94) and - 2.70 (95%CI - 2.75 to - 2.65), respectively. Meanwhile, decreasing trends were also observed in all SDI areas and geographic regions. The largest decreasing trends of death were observed in Thailand (EAPC = - 9.55, 95%CI - 10.48 to - 8.61). Among the attributable risks, behavioral risk-related death and DALYs caused by RHD had pronounced decreasing trends worldwide and in SDI areas.

CONCLUSIONS

Pronounced decreasing trends of death and DALYs caused by RHD were observed in regions and countries from 1990 to 2019, but the RHD burden remains a substantial challenge globally. The results would inform the strategies for more effective prevention and control of RHD.

摘要

背景

风湿性心脏病(Rheumatic Heart Disease,RHD)是全球范围内的一个重大公共卫生问题,其流行病学模式在过去几十年中发生了变化。本文旨在评估 1990 年至 2019 年全球 RHD 的趋势及其归因风险。

方法

从 2019 年全球疾病负担研究中获取 RHD 负担数据。使用估计的年百分比变化(EAPC)和年龄标准化率(ASR)来估计 RHD 负担趋势。

结果

1990 年至 2019 年期间,全球范围内 RHD 的发病率和患病率的 ASR 呈上升趋势,分别为 0.58(95%置信区间[CI]0.52-0.63)和 0.57(95%CI0.50-0.63)。同时,中低社会人口指数(Socio-Demographic Index,SDI)地区和国家的趋势普遍呈上升趋势。发病率和患病率的 ASR 上升幅度最大的国家是斐济,相应的 EAPC 分别为 2.17(95%CI1.48-2.86)和 2.22(95%CI1.53-2.91)。然而,风湿性心脏病导致的死亡和伤残调整生命年(Disability-Adjusted Life Years,DALYs)的 ASR 全球呈显著下降趋势,EAPC 分别为-2.98(95%CI-3.03-2.94)和-2.70(95%CI-2.75-2.65)。同时,所有 SDI 地区和地理区域也观察到了下降趋势。泰国的死亡归因风险下降幅度最大(EAPC=-9.55,95%CI-10.48 至-8.61)。在归因风险中,与行为风险相关的死亡和由 RHD 导致的 DALYs 呈全球和 SDI 地区显著下降趋势。

结论

1990 年至 2019 年期间,各地区和国家风湿性心脏病导致的死亡和 DALYs 呈显著下降趋势,但全球范围内 RHD 负担仍然是一个重大挑战。研究结果将为制定更有效的风湿性心脏病预防和控制策略提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f451/9188068/edae177ea793/13075_2022_2829_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f451/9188068/f60a0d855e73/13075_2022_2829_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f451/9188068/283cbe85f007/13075_2022_2829_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f451/9188068/d547caccf2fb/13075_2022_2829_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f451/9188068/e056f1d9e402/13075_2022_2829_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f451/9188068/edae177ea793/13075_2022_2829_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f451/9188068/f60a0d855e73/13075_2022_2829_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f451/9188068/283cbe85f007/13075_2022_2829_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f451/9188068/d547caccf2fb/13075_2022_2829_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f451/9188068/e056f1d9e402/13075_2022_2829_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f451/9188068/edae177ea793/13075_2022_2829_Fig5_HTML.jpg

相似文献

1
Global burden of rheumatic heart disease: trends from 1990 to 2019.风湿性心脏病全球负担:1990 年至 2019 年趋势。
Arthritis Res Ther. 2022 Jun 11;24(1):138. doi: 10.1186/s13075-022-02829-3.
2
Spatiotemporal trends in global burden of rheumatic heart disease and associated risk factors from 1990 to 2019.1990 年至 2019 年全球风湿性心脏病负担及相关危险因素的时空趋势。
Int J Cardiol. 2023 Aug 1;384:100-106. doi: 10.1016/j.ijcard.2023.04.060. Epub 2023 May 4.
3
Trends in burden of multidrug-resistant tuberculosis in countries, regions, and worldwide from 1990 to 2017: results from the Global Burden of Disease study.1990 年至 2017 年国家、地区和全球耐多药结核病负担趋势:来自全球疾病负担研究的结果。
Infect Dis Poverty. 2021 Mar 6;10(1):24. doi: 10.1186/s40249-021-00803-w.
4
Trends Analysis of Non-Hodgkin Lymphoma at the National, Regional, and Global Level, 1990-2019: Results From the Global Burden of Disease Study 2019.1990 - 2019年国家、区域和全球层面非霍奇金淋巴瘤的趋势分析:全球疾病负担研究2019的结果
Front Med (Lausanne). 2021 Sep 23;8:738693. doi: 10.3389/fmed.2021.738693. eCollection 2021.
5
Trends of cervical cancer at global, regional, and national level: data from the Global Burden of Disease study 2019.全球、区域和国家层面宫颈癌的发病趋势:来自《2019年全球疾病负担研究》的数据。
BMC Public Health. 2021 May 12;21(1):894. doi: 10.1186/s12889-021-10907-5.
6
Rheumatic Heart Disease Is a Neglected Disease Relative to Its Burden Worldwide: Findings From Global Burden of Disease 2019.风湿性心脏病是一种被忽视的疾病,相对于其在全球的负担:来自 2019 年全球疾病负担的研究结果。
J Am Heart Assoc. 2022 Jul 5;11(13):e025284. doi: 10.1161/JAHA.122.025284. Epub 2022 Jun 22.
7
Epidemiological study of pediatric rheumatic heart disease: An analysis from the Global Burden of Disease Study 2019.儿科风湿性心脏病的流行病学研究:来自 2019 年全球疾病负担研究的分析。
Int J Cardiol. 2024 Apr 1;400:131705. doi: 10.1016/j.ijcard.2023.131705. Epub 2024 Jan 1.
8
Analysis of the Global Burden of Disease study highlights the trends in death and disability-adjusted life years of leukemia from 1990 to 2017.分析全球疾病负担研究突出了 1990 年至 2017 年白血病的死亡和伤残调整生命年趋势。
Cancer Commun (Lond). 2020 Nov;40(11):598-610. doi: 10.1002/cac2.12094. Epub 2020 Sep 16.
9
Global burden of rheumatic heart disease and its association with socioeconomic development status, 1990-2019.风湿性心脏病的全球负担及其与社会经济发展状况的关联。1990-2019 年。
Eur J Prev Cardiol. 2022 Aug 5;29(10):1425-1434. doi: 10.1093/eurjpc/zwac044.
10
Analysis and comparison of the trends in burden of rheumatic heart disease in China and worldwide from 1990 to 2019.分析和比较 1990 年至 2019 年期间中国和全球风湿性心脏病负担的趋势。
BMC Cardiovasc Disord. 2023 Oct 24;23(1):517. doi: 10.1186/s12872-023-03552-w.

引用本文的文献

1
Rheumatic heart disease in Addis Ababa, Ethiopia, and the role of point-of-care ultrasound: a case series.埃塞俄比亚亚的斯亚贝巴的风湿性心脏病及床旁超声的作用:病例系列
CJEM. 2025 Jul 22. doi: 10.1007/s43678-025-00973-8.
2
An mRNA vaccine encoding five conserved Group A Streptococcus antigens.一种编码五种保守A群链球菌抗原的信使核糖核酸疫苗。
Nat Commun. 2025 Jul 1;16(1):5439. doi: 10.1038/s41467-025-60580-0.
3
New evidence supports a greater focus on streptococcal skin infections to prevent rheumatic fever.新证据支持更关注链球菌性皮肤感染以预防风湿热。

本文引用的文献

1
The personal and clinical impact of screen-detected maternal rheumatic heart disease in Uganda: a prospective follow up study.在乌干达,屏幕检测到的母体风湿性心脏病对个人和临床的影响:一项前瞻性随访研究。
BMC Pregnancy Childbirth. 2020 Oct 9;20(1):611. doi: 10.1186/s12884-020-03189-z.
2
Trends in prevalence, mortality, and morbidity associated with high systolic blood pressure in Brazil from 1990 to 2017: estimates from the "Global Burden of Disease 2017" (GBD 2017) study.1990 年至 2017 年巴西与收缩压高相关的流行率、死亡率和发病率趋势:来自“全球疾病负担 2017”(GBD 2017)研究的估计。
Popul Health Metr. 2020 Sep 30;18(Suppl 1):17. doi: 10.1186/s12963-020-00218-z.
3
Med J Aust. 2025 Aug 4;223(3):114-116. doi: 10.5694/mja2.52708. Epub 2025 Jun 18.
4
Severe adverse reactions to benzathine penicillin G in rheumatic heart disease: A systematic review and meta-analysis.风湿性心脏病患者对苄星青霉素G的严重不良反应:一项系统评价和荟萃分析。
PLoS One. 2025 May 7;20(5):e0322873. doi: 10.1371/journal.pone.0322873. eCollection 2025.
5
Upstream and Downstream Cardiovascular Changes in Rheumatic Mitral Stenosis: An Update.风湿性二尖瓣狭窄的上下游心血管变化:最新进展
J Clin Med. 2025 Apr 11;14(8):2639. doi: 10.3390/jcm14082639.
6
Prevalence of Rheumatic Heart Disease in First-Degree Relatives of Index-Cases: A Systematic Review and Meta-Analysis.先证者一级亲属中风湿性心脏病的患病率:一项系统评价和荟萃分析
Glob Heart. 2025 Mar 10;20(1):24. doi: 10.5334/gh.1417. eCollection 2025.
7
BASELINE CLINICAL CHARACTERISTICS OF CONTEMPORARY ADULT CHRONIC RHEUMATIC HEART DISEASE IN IBADAN, NIGERIA.尼日利亚伊巴丹当代成人慢性风湿性心脏病的基线临床特征
Ann Ib Postgrad Med. 2024 Aug 30;22(2):9-17.
8
Recent Advances on the Prevention and Management of Rheumatic Heart Disease.风湿性心脏病预防与管理的最新进展
Glob Heart. 2025 Feb 21;20(1):17. doi: 10.5334/gh.1402. eCollection 2025.
9
Acceptability and Implementation Challenges of Benzathine Penicillin G Secondary Prophylaxis for Rheumatic Heart Disease in Ethiopia: A Qualitative Study.苄星青霉素G二级预防埃塞俄比亚风湿性心脏病的可接受性与实施挑战:一项定性研究
Glob Heart. 2025 Jan 29;20(1):8. doi: 10.5334/gh.1393. eCollection 2025.
10
Valvular Heart Disease-Related Mortality Between Middle- and High-Income Countries During 2000 to 2019.2000年至2019年中高收入国家与心脏瓣膜病相关的死亡率
JACC Adv. 2024 Aug 28;3(12):101133. doi: 10.1016/j.jacadv.2024.101133. eCollection 2024 Dec.
Continuing Burden of Rheumatic Heart Disease in India.
印度风湿性心脏病的持续负担
J Assoc Physicians India. 2020 Oct;68(10):60-65.
4
Analysis of the Global Burden of Disease study highlights the trends in death and disability-adjusted life years of leukemia from 1990 to 2017.分析全球疾病负担研究突出了 1990 年至 2017 年白血病的死亡和伤残调整生命年趋势。
Cancer Commun (Lond). 2020 Nov;40(11):598-610. doi: 10.1002/cac2.12094. Epub 2020 Sep 16.
5
Rheumatic heart disease anno 2020: Impacts of gender and migration on epidemiology and management.2020 年风湿性心脏病:性别和移民对流行病学和管理的影响。
Eur J Clin Invest. 2020 Dec;50(12):e13374. doi: 10.1111/eci.13374. Epub 2020 Aug 29.
6
Incidence of acute rheumatic fever and rheumatic heart disease in Melbourne, Australia from 1937 to 2013.1937年至2013年澳大利亚墨尔本急性风湿热和风湿性心脏病的发病率。
J Paediatr Child Health. 2020 Sep;56(9):1408-1413. doi: 10.1111/jpc.14950. Epub 2020 Jul 8.
7
Compliance to the secondary prophylaxis and awareness of rheumatic heart disease: A cross-sectional study in low-income province of India.风湿性心脏病二级预防的依从性及认知情况:印度低收入省份的一项横断面研究
J Family Med Prim Care. 2020 Mar 26;9(3):1431-1435. doi: 10.4103/jfmpc.jfmpc_1056_19. eCollection 2020 Mar.
8
The cost-of-illness due to rheumatic heart disease: national estimates for Fiji.风湿性心脏病所致疾病负担:斐济国家估计数。
Trans R Soc Trop Med Hyg. 2020 Jul 1;114(7):483-491. doi: 10.1093/trstmh/trz118.
9
Death burden of high systolic blood pressure in Sichuan Southwest China 1990-2030.1990-2030 年中国西南四川地区高收缩压导致的死亡负担。
BMC Public Health. 2020 Mar 29;20(1):406. doi: 10.1186/s12889-020-8377-6.
10
Voices behind the Statistics: A Systematic Literature Review of the Lived Experience of Rheumatic Heart Disease.风湿性心脏病患者的生活体验:系统文献回顾中的声音
Int J Environ Res Public Health. 2020 Feb 19;17(4):1347. doi: 10.3390/ijerph17041347.